Andrei Thomas‐Tikhonenko

10.2k total citations · 3 hit papers
81 papers, 6.0k citations indexed

About

Andrei Thomas‐Tikhonenko is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Andrei Thomas‐Tikhonenko has authored 81 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 29 papers in Oncology and 22 papers in Immunology. Recurrent topics in Andrei Thomas‐Tikhonenko's work include RNA modifications and cancer (15 papers), CAR-T cell therapy research (13 papers) and Lymphoma Diagnosis and Treatment (12 papers). Andrei Thomas‐Tikhonenko is often cited by papers focused on RNA modifications and cancer (15 papers), CAR-T cell therapy research (13 papers) and Lymphoma Diagnosis and Treatment (12 papers). Andrei Thomas‐Tikhonenko collaborates with scholars based in United States, Russia and United Kingdom. Andrei Thomas‐Tikhonenko's co-authors include Duonan Yu, Erik A. Wentzel, Joshua T. Mendell, Michael Dews, Chi V. Dang, Tsung-Cheng Chang, Dan E. Arking, Yun‐Sil Lee, Ravi K. Amaravadi and Craig B. Thompson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Andrei Thomas‐Tikhonenko

79 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Widespread microRNA repression by Myc contributes to tumorigenesis

2007 1.1k citations Duonan Yu, Erik A. Wentzel et al. Nature Genetics profile →
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma

2007 936 citations Duonan Yu, Andrei Thomas‐Tikhonenko et al. profile →
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

2006 851 citations Michael Dews, Duonan Yu et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrei Thomas‐Tikhonenko United States	35	4.5k	2.9k	1.2k	871	700	81	6.0k
Ai‐Wu Ke China	41	3.7k 0.8×	2.2k 0.8×	1.4k 1.2×	1.1k 1.2×	950 1.4×	93	5.9k
Amaia Lujambio United States	27	4.2k 0.9×	2.8k 1.0×	1.2k 1.1×	445 0.5×	764 1.1×	54	6.1k
Min Sup Song United States	25	4.2k 0.9×	1.5k 0.5×	1.1k 1.0×	391 0.4×	408 0.6×	53	5.3k
Shi‐Mei Zhuang China	43	5.4k 1.2×	4.5k 1.6×	957 0.8×	611 0.7×	823 1.2×	88	7.5k
David J. Wong United States	22	5.7k 1.3×	4.3k 1.5×	1.1k 0.9×	434 0.5×	688 1.0×	28	7.7k
Yunfei Yuan China	51	4.8k 1.1×	3.7k 1.3×	1.7k 1.4×	1.1k 1.3×	819 1.2×	187	8.2k
Christine M. Eischen United States	44	5.0k 1.1×	1.5k 0.5×	3.1k 2.6×	356 0.4×	1.1k 1.5×	99	6.8k
Silvia Montaner United States	31	1.9k 0.4×	956 0.3×	1.6k 1.4×	803 0.9×	631 0.9×	60	4.2k
Limin Xia China	39	2.8k 0.6×	1.4k 0.5×	1.0k 0.9×	356 0.4×	594 0.8×	142	4.1k
Philip H. Howe United States	46	3.7k 0.8×	1.1k 0.4×	1.6k 1.3×	276 0.3×	788 1.1×	104	5.2k

Countries citing papers authored by Andrei Thomas‐Tikhonenko

Since Specialization

Citations

This map shows the geographic impact of Andrei Thomas‐Tikhonenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrei Thomas‐Tikhonenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrei Thomas‐Tikhonenko more than expected).

Fields of papers citing papers by Andrei Thomas‐Tikhonenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrei Thomas‐Tikhonenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrei Thomas‐Tikhonenko. The network helps show where Andrei Thomas‐Tikhonenko may publish in the future.

Co-authorship network of co-authors of Andrei Thomas‐Tikhonenko

This figure shows the co-authorship network connecting the top 25 collaborators of Andrei Thomas‐Tikhonenko. A scholar is included among the top collaborators of Andrei Thomas‐Tikhonenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrei Thomas‐Tikhonenko. Andrei Thomas‐Tikhonenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Torres-Diz, Manuel, Clara Reglero, Katharina E. Hayer, et al.. (2024). An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia. Cancer Research. 84(20). 3327–3336. 3 indexed citations

DAVIS, J, Katharina E. Hayer, Sisi Zheng, et al.. (2024). PAX5 Loss Compromises CD22 Protein Levels and Responses to Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 4170–4170.

Anczuków, Olga, Frédéric H.‐T. Allain, Brittany Angarola, et al.. (2024). Steering research on mRNA splicing in cancer towards clinical translation. Nature reviews. Cancer. 24(12). 887–905. 8 indexed citations

Thomas‐Tikhonenko, Andrei, et al.. (2024). Contrasting and combining transcriptome complexity captured by short and long RNA sequencing reads. Genome Research. 34(10). 1624–1635. 5 indexed citations

Quesnel-Vallières, Mathieu, et al.. (2023). MAJIQlopedia: an encyclopedia of RNA splicing variations in human tissues and cancer. Nucleic Acids Research. 52(D1). D213–D221. 7 indexed citations

Closa, Adrià, Antonio C. Fuentes-Fayos, Katharina E. Hayer, et al.. (2022). A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1. NAR Cancer. 4(4). zcac041–zcac041. 5 indexed citations

Yang, Scarlett Y., Katharina E. Hayer, Hossein Fazelinia, et al.. (2022). FBXW7β isoform drives transcriptional activation of the proinflammatory TNF cluster in human pro-B cells. Blood Advances. 7(7). 1077–1091. 3 indexed citations

Lanauze, Claudia, Priyanka Sehgal, Katharina E. Hayer, et al.. (2021). Colorectal Cancer-Associated Smad4 R361 Hotspot Mutations Boost Wnt/β-Catenin Signaling through Enhanced Smad4–LEF1 Binding. Molecular Cancer Research. 19(5). 823–833. 9 indexed citations

Harrington, Colleen T., Elena Sotillo, Chi V. Dang, & Andrei Thomas‐Tikhonenko. (2021). Tilting MYC toward cancer cell death. Trends in cancer. 7(11). 982–994. 17 indexed citations

10.

Naqvi, Ammar S., Gerald Wertheim, Michele Paessler, et al.. (2017). Semi-Quantitative Analysis of CD19 and CD22 Expression in B-Lymphoblastic Leukemia and Implications for Targerted Immunotherapy. Blood. 130. 1331–1331. 2 indexed citations

11.

Dews, Michael, et al.. (2012). Targeting of TGFβ signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma. RNA. 19(2). 177–190. 43 indexed citations

12.

Hultine, Stacy, Lauren M. Smith, Michael Dews, et al.. (2011). p53-Responsive miR-194 Inhibits Thrombospondin-1 and Promotes Angiogenesis in Colon Cancers. Cancer Research. 71(24). 7490–7501. 135 indexed citations

13.

Mestdagh, Pieter, Francis Impens, Erik Fredlund, et al.. (2011). The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma. Ghent University Academic Bibliography (Ghent University). 41 indexed citations

14.

Chayka, Olesya, Daisy Corvetta, Michael Dews, et al.. (2009). Clusterin, a Haploinsufficient Tumor Suppressor Gene in Neuroblastomas. JNCI Journal of the National Cancer Institute. 101(9). 663–677. 68 indexed citations

15.

Wei, Fang, et al.. (2006). Epigenetic Histone Modifications Do Not Control Igκ Locus Contraction and Intranuclear Localization in Cells with Dual B Cell-Macrophage Potential. The Journal of Immunology. 177(9). 6165–6171. 7 indexed citations

16.

O’Donnell, Kathryn A., Duonan Yu, Karen Zeller, et al.. (2006). Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis. Molecular and Cellular Biology. 26(6). 2373–2386. 195 indexed citations

17.

Dews, Michael, Duonan Yu, Danielle Murphy, et al.. (2006). Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genetics. 38(9). 1060–1065. 851 indexed citations breakdown →

18.

Patel, Jagruti, et al.. (2005). Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proceedings of the National Academy of Sciences. 102(39). 13968–13973. 99 indexed citations

19.

Thomas‐Tikhonenko, Andrei & Christopher A. Hunter. (2002). Infection and cancer: the common vein. Cytokine & Growth Factor Reviews. 14(1). 67–77. 24 indexed citations

20.

Hunter, Christopher A., Duonan Yu, Michael S. Gee, et al.. (2001). Cutting Edge: Systemic Inhibition of Angiogenesis Underlies Resistance to Tumors During Acute Toxoplasmosis. The Journal of Immunology. 166(10). 5878–5881. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact